Comparison of central and peripheral pharmacologic effects of biperiden and trihexyphenidyl in human volunteers

Journal of Clinical Psychopharmacology

Volumn 20, Issue 1, 2000, Pages 77-83

  Guthrie, Sally K ^a,b   Manzey, Laura ^a   Scott, Doneka ^a   Giordani, Bruno ^a   Tandon, Rajiv ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; PLACEBO; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; LONG TERM MEMORY; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; RECALL; RR INTERVAL; SALIVATION; SCHIZOPHRENIA; VERTIGO;

ADOLESCENT; ADULT; BIPERIDEN; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MENTAL RECALL; MUSCARINIC ANTAGONISTS; PLACEBOS; PSYCHOMOTOR PERFORMANCE; SALIVATION; TRIHEXYPHENIDYL;

EID: 0033972297     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200002000-00013     Document Type: Article

References (18)

1. Buckley NJ, Bonner TI, Buckley CM, Brann MR. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 1989;35:469-76.
2. Brann MR, Jorgensen HB, Burstein ES, Spalding TA, Ellis J, Jones SVP, Hill-Eubanks D. Studies of the pharmacology, localization, and structure of muscarinic acetylcholine receptors. Ann N Y Acad Sci 1993;707:225-36.
3. Bolden C, Cusack B, Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at five cloned human muscarinic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 1992;260:576-80.
4. Schreiber G, Belmaker RH. In vivo differentiation of cardiac vagal blocking effects of chlorpromazine and haloperidol. Biol Psychiatry 1987;22:1417-21.
5. Mikkelsen PL, Clemmesen L, Lund H, Bolwig TG, Rafaelsen OJ. Hyposalivation after single doses of antidepressants. Int Pharmacopsychiatry 1982;17[suppl 1]:35-42.
6. Buschke H. Selective reminding for analysis of memory and learning. J Verb Learn Verb Behav 1973;12:543-50.
7. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1995.
8. SAS Institute. SAS software, version 6.12. Cary, NC: SAS Institute, 1996.
9. McEvoy JP, McCue M, Spring B, Mohs RC, Lavori PW, Farr RM. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers. Am J Psychiatry 1987;144:573-7.
10. Fennig S, Levine Y, Naisberg S, Elizur A. The effect of trihexyphenidyl (Artane) on memory in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 1986;11:71-8.
11. Casadei B, Conway J, Forfar C, Sleight P. Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart 1996;75:274-80.
12. Wellstein A, Pitschner HF. Complex dose-response curves of atropine in man explained by different functions of M1 and M2-cholinoceptors. Naunyn Schmiedebergs Arch Pharmacol 1988; 338:19-27.
13. Brodde O-E, Konschak U, Becker K, Rüter F, Poller U, Jakubetz J, Radke J, Zerkowski H-R. Cardiac muscarinic receptors decrease with age. J Clin Invest 1998;101:471-8.
14. Grimaldi R, Perucca E, Ruberto G, Gelmi C, Trimarchi F, Hollmann M, Crema A. Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects. Eur J Clin Pharmacol 1986;29:735-7.
15. He H, McKay G, Wirshing B, Midha KK. Development and application of a specific and sensitive radioimmonoassay for trihexyphenidyl to a pharmacokinetic study in humans. J Pharm Sci 1995;84:561-7.
16. McEvoy JP, Freter S. The dose-response relationship for memory impairment by anticholinergic drugs. Compr Psychiatry 1989;30: 135-8.
17. Perlick D, Stastny P, Katz I, Mayer M, Mattis S. Memory deficits and anticholinergic levels in chronic schizophrenia. Am J Psychiatry 1986;143:230-2.
18. Zeng XP, Le F, Richelson E. Muscarinic M4 receptor activation by some atypical antipsychotic drugs. Eur J Pharmacol 1997;321:349-54.